Cargando…
The Quinazoline Otaplimastat (SP-8203) Reduces the Hemorrhagic Transformation and Mortality Aggravated after Delayed rtPA-Induced Thrombolysis in Cerebral Ischemia
Acute ischemic stroke is the leading cause of morbidity and mortality worldwide. Recombinant tissue plasminogen activator (rtPA) is the only agent clinically approved by FDA for patients with acute ischemic stroke. However, delayed treatment of rtPA (e.g., more than 3 h after stroke onset) exacerbat...
Autores principales: | Song, Hwa Young, Chung, Jee-In, Jalin, Angela Melinda Anthony, Ju, Chung, Pahk, Kisoo, Joung, Chanmin, Lee, Sekwang, Jin, Sejong, Kim, Byoung Soo, Lee, Ki Sung, Ryu, Jei-Man, Kim, Won-Ki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835804/ https://www.ncbi.nlm.nih.gov/pubmed/35163322 http://dx.doi.org/10.3390/ijms23031403 |
Ejemplares similares
-
Successful systemic thrombolysis with rtPA in a patient with history of a life-threatening rtPA-associated orolingual angioedema
por: Pelz, Johann Otto, et al.
Publicado: (2017) -
Investigation of the long-term healing response of the liver to boiling histotripsy treatment in vivo
por: Heo, Jeongmin, et al.
Publicado: (2022) -
Noninvasive mechanical destruction of liver tissue and tissue decellularisation by pressure-modulated shockwave histotripsy
por: Pahk, Ki Joo, et al.
Publicado: (2023) -
Enhanced Cerebroprotection of Xenon-Loaded Liposomes in Combination with rtPA Thrombolysis for Embolic Ischemic Stroke
por: Peng, Tao, et al.
Publicado: (2023) -
Safety and Efficacy of Otaplimastat in Patients with Acute Ischemic Stroke Requiring tPA (SAFE‐TPA): A Multicenter, Randomized, Double‐Blind, Placebo‐Controlled Phase 2 Study
por: Kim, Jong S., et al.
Publicado: (2019)